Gender and urinary pH affect melamine-associated kidney stone formation risk

Urology Annals

Volumn 3, Issue 2, 2011, Pages 71-74

  Lu, Xiuli ^a   Wang, Jing ^b   Cao, Xiangyu ^a   Li, Mingxin ^c   Xiao, Chunling ^a   Yasui, Takahiro ^d   Gao, Bing ^a  

^a LIAONING UNIVERSITY   (China)

^b Fourth People's Hospital of Shenyang   (China)

^c Department of Clinical Laboratory Sciences   (China)

^d NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Kidney stone; melamine; urinary pH

Indexed keywords

MELAMINE;

ACIDURIA; AGE; ARTICLE; ARTIFICIAL MILK; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOOD CONTAMINATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SEX DIFFERENCE; URINALYSIS; URINE PH;

EID: 79959998999     PISSN: 09747796     EISSN: 09747834     Source Type: Journal    
DOI: 10.4103/0974-7796.82171     Document Type: Article

References (20)

1. Uribarri J, Oh MS, Carroll HJ. The first kidney stone. Ann Intern Med 1989;111:1006-9. (Pubitemid 20034925)
2. Xinhua. Available from: http://news.xinhuanet.com/fortune/2008-12/27/ content-10569105.htm. [last cited on 2008].
3. Ho SS, Chu WC, Wong KT, Li CK, Wong W, Ng PC, et al. Ultrasonographic evaluation of melamine-exposed children in Hong Kong. N Engl J Med 2009;360:1156-7.
4. Hocking B. Melamine-contaminated powdered formula and urolithiasis. N Engl J Med 2009;360:2676-7.
5. Ji K, Zhu S, Liu Z. Melamine-contaminated powdered formula and urolithiasis. N Engl J Med 2009;360:2675-6.
6. Li G, Jiao S, Yin X, Deng Y, Pang X, Wang Y. The risk of melamineinduced nephrolithiasis in young children starts at a lower intake level than recommended by the WHO. Pediatr Nephrol 2010;25:135-41.
7. Guan N, Fan Q, Ding J, Zhao Y, Lu J, Ai Y, et al. Melamine-contaminated powdered formula and urolithiasis in young children. N Engl J Med 2009;360:1067-74.
8. Lam CW, Lan L, Che X, Tam S, Wong SS, Chen Y, et al. Diagnosis and spectrum of melamine-related renal disease: plausible mechanism of stone formation in humans. Clin Chim Acta 2009;402:150-5.
9. Hess B. Acid-base metabolism: implications for kidney stones formation. Urol Res 2006;34:134-8.
10. Maalouf NM, Cameron MA, Moe OW, ms-Huet B, Sakhaee K. Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2007;2:883-8.
11. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest 2005;115:2598-608. (Pubitemid 41434382)
12. Baynes RE, Smith G, Mason SE, Barrett E, Barlow BM, Riviere JE. Pharmacokinetics of melamine in pigs following intravenous administration. Food Chem Toxicol 2008;46:1196-200.
13. Mast RW, Jeffcoat AR, Sadler BM, Kraska RC, Friedman MA. Metabolism, disposition and excretion of [14C]melamine in male Fischer 344 rats. Food Chem Toxicol 1983;21:807-10. (Pubitemid 14216195)
14. Canelli E. Chemical, bacteriological, and toxicological properties of cyanuric acid and chlorinated isocyanurates as applied to swimming pool disinfection: a review. Am J Public Health 1974;64:155-62.
15. Wang IJ, Chen PC, Hwang KC. Melamine and nephrolithiasis in children in Taiwan. N Engl J Med 2009;360:1157-8.
16. Akizuki S. Serum uric acid levels among thirty-four thousand people in Japan. Ann Rheum Dis 1982;41:272-4. (Pubitemid 12087766)
17. Adamopoulos D, Vlassopoulos C, Seitanides B, Contoyiannis P, Vassilopoulos P. The relationship of sex steroids to uric acid levels in plasma and urine. Acta Endocrinol (Copenh) 1977;85:198-208. (Pubitemid 8087786)
18. Heller HJ, Sakhaee K, Moe OW, Pak CY. Etiological role of estrogen status in renal stone formation. J Urol 2002;168:1923-7.
19. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003;63:1817-23. (Pubitemid 36513328)
20. Brikowski TH, Lotan Y, Pearle MS. Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci USA 2008;105:9841-6. (Pubitemid 352031387)